These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7533023)

  • 1. Possible functional groups responsible for inhibition of in vivo angiogenesis by herbimycin A.
    Oikawa T; Ogasawara H; Sano H; Shibata K; Omura S
    Biol Pharm Bull; 1994 Oct; 17(10):1430-2. PubMed ID: 7533023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Powerful antiangiogenic activity of herbimycin A (named angiostatic antibiotic).
    Oikawa T; Hirotani K; Shimamura M; Ashino-Fuse H; Iwaguchi T
    J Antibiot (Tokyo); 1989 Jul; 42(7):1202-4. PubMed ID: 2473973
    [No Abstract]   [Full Text] [Related]  

  • 3. Eponemycin, a novel antibiotic, is a highly powerful angiogenesis inhibitor.
    Oikawa T; Hasegawa M; Shimamura M; Ashino H; Murota S; Morita I
    Biochem Biophys Res Commun; 1991 Dec; 181(3):1070-6. PubMed ID: 1722395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A highly potent antiangiogenic activity of retinoids.
    Oikawa T; Hirotani K; Nakamura O; Shudo K; Hiragun A; Iwaguchi T
    Cancer Lett; 1989 Nov; 48(2):157-62. PubMed ID: 2479461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new image analysis method for the quantification of neovascularization.
    Voss K; Jacob W; Roth K
    Exp Pathol; 1984; 26(3):155-61. PubMed ID: 6083879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of angiogenesis by rhizoxin, a microbial metabolite containing two epoxide groups.
    Onozawa C; Shimamura M; Iwasaki S; Oikawa T
    Jpn J Cancer Res; 1997 Dec; 88(12):1125-9. PubMed ID: 9473728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The modifying action of tumor necrosis factor on angiogenesis].
    Lisniak IA; Sopotsinskaia EB; Kudriavets IuI
    Eksp Onkol; 1989; 11(3):50-2. PubMed ID: 2473876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new activity of herbimycin A: inhibition of angiogenesis.
    Yamashita T; Sakai M; Kawai Y; Aono M; Takahashi K
    J Antibiot (Tokyo); 1989 Jun; 42(6):1015-7. PubMed ID: 2472371
    [No Abstract]   [Full Text] [Related]  

  • 9. Potent inhibition of angiogenesis by wortmannin, a fungal metabolite.
    Oikawa T; Shimamura M
    Eur J Pharmacol; 1996 Dec; 318(1):93-6. PubMed ID: 9007518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth and angiogenesis are inhibited in vivo in developing tissues by pyrazine and its derivatives.
    Melkonian G; Eckelhoefer H; Wu M; Wang Y; Tong C; Riveles K; Talbot P
    Toxicol Sci; 2003 Oct; 75(2):393-401. PubMed ID: 12773771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the mast cell activator compound 48/80 and heparin on angiogenesis in the chick chorioallantoic membrane.
    Clinton M; Long WF; Williamson FB; Duncan JI; Thompson WD
    Int J Microcirc Clin Exp; 1988 Nov; 7(4):315-26. PubMed ID: 2464553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemical modification and antitumor activity of herbimycin A. 8,9-Epoxide, 7,9-cyclic carbamate, and 17 or 19-amino derivatives.
    Omura S; Miyano K; Nakagawa A; Sano H; Komiyama K; Umezawa I; Shibata K; Satsumabayashi S
    J Antibiot (Tokyo); 1984 Oct; 37(10):1264-7. PubMed ID: 6501098
    [No Abstract]   [Full Text] [Related]  

  • 13. Radicicol, a microbial cell differentiation modulator, inhibits in vivo angiogenesis.
    Oikawa T; Ito H; Ashino H; Toi M; Tominaga T; Morita I; Murota S
    Eur J Pharmacol; 1993 Sep; 241(2-3):221-7. PubMed ID: 7694864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-angiogenic activity of triterpene acids.
    Sohn KH; Lee HY; Chung HY; Young HS; Yi SY; Kim KW
    Cancer Lett; 1995 Aug; 94(2):213-8. PubMed ID: 7543366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of herbimycin derivatives on src oncogene function in relation to antitumor activity.
    Uehara Y; Murakami Y; Suzukake-Tsuchiya K; Moriya Y; Sano H; Shibata K; Omura S
    J Antibiot (Tokyo); 1988 Jun; 41(6):831-4. PubMed ID: 3403381
    [No Abstract]   [Full Text] [Related]  

  • 16. Induction of angiogenic response by chemically stable prostacyclin analogs.
    Ohtsu A; Fujii K; Kurozumi S
    Prostaglandins Leukot Essent Fatty Acids; 1988 Jul; 33(1):35-9. PubMed ID: 2460880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiogenic stimulation compared with angiogenic reaction to injury: distinction by focal and general application of trypsin to the chick chorioallantoic membrane.
    Thompson WD; Kazmi MA
    Br J Exp Pathol; 1989 Dec; 70(6):627-35. PubMed ID: 2481488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effects of anti-angiogenic agents on neovascularization and growth of the chorioallantoic membrane (CAM). The possibility of a new CAM assay for angiogenesis inhibition.
    Tanaka NG; Sakamoto N; Tohgo A; Nishiyama Y; Ogawa H
    Exp Pathol; 1986; 30(3):143-50. PubMed ID: 2431923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of angiogenesis by mixtures of two angiogenic proteins, angiogenin and acidic fibroblast growth factor, in the chick chorioallantoic membrane.
    Fett JW; Bethune JL; Vallee BL
    Biochem Biophys Res Commun; 1987 Aug; 146(3):1122-31. PubMed ID: 2441701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of angiogenesis by humulone, a bitter acid from beer hop.
    Shimamura M; Hazato T; Ashino H; Yamamoto Y; Iwasaki E; Tobe H; Yamamoto K; Yamamoto S
    Biochem Biophys Res Commun; 2001 Nov; 289(1):220-4. PubMed ID: 11708802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.